CHEK2 1100delC in Patients With Metachronous Cancers of the Breast and the Colorectum

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-6-64
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The CHEK2 1100delC Mutation Identifies Families With a Hereditary Breast and Colorectal Cancer Phenotype

American Journal of Human Genetics
Genetics
2003English

Evaluation of Metachronous Breast and Endometrial Cancers

International Journal of Gynecological Cancer
GynecologyOncologyObstetrics
2016English

CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

BRAF Mutation Is Associated With DNA Methylation in Serrated Polyps and Cancers of the Colorectum

Gut
Gastroenterology
2004English

Metachronous or Synchronous Male Breast and Prostate Cancers a Duality to Lookout For.

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2019English

Metachronous Triplicated Primary Cancers: A Case Report.

Journal of Japan Society for Oral Tumors
1993English

Primary Small Cell Carcinoma of Lung With Metachronous Breast Metastasis

Serbian Journal of Experimental and Clinical Research
Medicine
2017English

Association Between CHEK2 H371Y Mutation and Response to Neoadjuvant Chemotherapy in Women With Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

GnRH Antagonists in the Treatment of Gynecological and Breast Cancers

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy